Levetiracetam Stragen

Levetiracetam, the active ingredient in Levetiracetam Stragen, is an anticonvulsant presented as an intravenous solution for parenteral use. It treats partial‑onset, myoclonic and primary generalized tonic‑clonic seizures in patients requiring seizure control.

GNH USA supplies Levetiracetam Stragen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and transplant centres worldwide.

Levetiracetam is an antiepileptic drug used to manage various seizure types.

- Partial‑onset seizures: reduces the frequency of focal seizures in adults and children. - Myoclonic seizures: controls rapid, involuntary muscle jerks associated with juvenile myoclonic epilepsy. - Primary generalized tonic‑clonic seizures: prevents generalized convulsive episodes in patients with idiopathic generalized epilepsy.

Levetiracetam may be associated with a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects: - Dizziness: sensation of lightheadedness or unsteadiness. - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate head pain. - Irritability: mood changes or increased agitation.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood or behavior changes: depression, suicidal thoughts, or aggression. - Hematologic abnormalities: low blood cell counts such as leukopenia or thrombocytopenia.

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use.

- Renal impairment: adjust dose in patients with reduced kidney function. - History of psychiatric disorders: monitor for mood changes or suicidal ideation. - Concomitant CNS depressants: use caution as additive sedation may occur. - Pregnancy: potential risks are unknown; evaluate benefit‑risk ratio. - Lactation: unknown safety; consider alternatives or monitor infant. - Store at ambient temperature: keep in original container, protect from moisture and light.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - None identified: no major drug interactions have been documented.

Moderate Interactions (Monitor Closely): - Carbamazepine, phenytoin, phenobarbital: enzyme inducers may lower levetiracetam concentrations. - Valproic acid: may increase levetiracetam levels modestly. - Sedative agents (benzodiazepines, opioids): additive CNS depression may occur. - Oral contraceptives: levetiracetam may reduce hormonal contraceptive efficacy.